Commodore Capital’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.41M Hold
483,000
0.17% 33
2025
Q1
$3.87M Hold
483,000
0.29% 31
2024
Q4
$3.59M Hold
483,000
0.26% 29
2024
Q3
$4.59M Buy
483,000
+443,000
+1,108% +$4.21M 0.29% 36
2024
Q2
$499K Buy
+40,000
New +$499K 0.03% 35